Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
SAN FRANCISCO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel...
News
Tizona Therapeutics Announces Expansion of Phase 1b Clinical Trial to Evaluate TTX-080 in Combination with EGFR Inhibitor Cetuximab and Chemotherapy in Advanced Colorectal Cancer
Trial builds upon promising evidence of clinical activity of TTX-080 when combined cetuximab, presented at ASCO 2024SOUTH SAN FRANCISCO, Calif.,...
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
Accomplished Finance and Commercial Leader Brings Extensive Life Sciences ExpertiseCAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc....
New Treatments, Novel Research Drive Better Survival Rates for Canadians with Lung Cancer, Offering Hope to Thousands: Lung Health Foundation
Lung Cancer Awareness Month: Survivors Share Stories of Hope and Resilience Amid Revolutionary Medical BreakthroughsTORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE)...
Edesa Biotech’s Founder Makes Strategic Investment in the Company
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics...
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
Special Meeting of Stockholders Adjourned Due to Lack of QuorumSAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc....
Merus Announces Financial Results for the Third Quarter 2024 and Provides Business Update
Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling...
Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference
Late-breaking presentation highlights the pTau217 assay as an effective and efficient tool to screen participants for ALTITUDE-AD that reduces unnecessary...
MaxCyte to Participate in Two Upcoming Investor Conferences
ROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing...
Hisense named first Official Partner of the FIFA Club World Cup 2025™
DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, announced it has...
Global Times: China’s AI tech brings more convenient, dignified life to people with disabilities and their families
BEIJING, Oct. 31, 2024 /PRNewswire/ -- When Yong Yong (pseudonym) navigates through the bustling exhibition hall, a soothing voice whisperers in...
Amid Rising Costs, XRP Healthcare Prescription Savings Card Making a Difference at 68,000 Pharmacies Across America: A Game-Changer for Individuals and Organizations Alike
DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Amid rising costs in the U.S., the XRP Healthcare Prescription Savings Card is providing...
MGI’s DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024
SHENZHEN, China, Oct. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies...
Fangzhou Inc. Garners Industry Recognition as an Innovator in AI Technology
GUANGZHOU, China, Oct. 30, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou") (06086.HK), a leader in Internet healthcare solutions, was featured on the...
Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement
Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased...
Siemens strengthens leadership in industrial software and AI with acquisition of Altair Engineering
Acquisition of Altair Engineering Inc., a global leader in computational science and artificial intelligence software, strengthens Siemens' position as a...
Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024
Company to host a conference call tomorrow at 8:00 a.m. ET NEWTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Karyopharm Therapeutics...
Laguna Health Has Been Selected for TIME’s List of the Best Inventions of 2024
Digital Health Industry's Leading Conversational Care Intelligence Companion Chosen for TIME Best Inventions in Artificial Intelligence NEW YORK, Oct. 30,...
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
BURLINGTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome...
Invest Smart, Grow Fast! Industries with Up to 20% Annual Growth
"Discover High-Growth Opportunities Across Leading Sectors, With BCC Research Highlighting Industries Primed for Up to 20% Annual Returns" BOSTON, Oct....